Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Other Non Operating Income: 2011-2024

Historic Other Non Operating Income for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $9.6 million.

  • Veracyte's Other Non Operating Income fell 183.98% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 59.31%. This contributed to the annual value of $9.6 million for FY2024, which is 4.56% up from last year.
  • Latest data reveals that Veracyte reported Other Non Operating Income of $9.6 million as of FY2024, which was up 4.56% from $9.2 million recorded in FY2023.
  • Veracyte's Other Non Operating Income's 5-year high stood at $9.6 million during FY2024, with a 5-year trough of $254,000 in FY2021.
  • Over the past 3 years, Veracyte's median Other Non Operating Income value was $9.2 million (recorded in 2023), while the average stood at $7.8 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first slumped by 81.01% in 2020, then soared by 1,732.28% in 2022.
  • Yearly analysis of 5 years shows Veracyte's Other Non Operating Income stood at $480,000 in 2020, then tumbled by 47.08% to $254,000 in 2021, then soared by 1,732.28% to $4.7 million in 2022, then skyrocketed by 97.31% to $9.2 million in 2023, then increased by 4.56% to $9.6 million in 2024.